Core Viewpoint - The article emphasizes the importance of "non-grain" raw materials in the future of the bio-manufacturing industry, highlighting the recent funding round of nearly 300 million yuan for Weiyuan Synthesis to accelerate the development of methanol-based bio-manufactured products [2][3]. Group 1: Industry Trends - The bio-manufacturing sector is positioned as a key driver for future industrial transformation, with McKinsey predicting that 60% of global material production could be synthesized biologically [2]. - The current reliance on starch sugars for bio-based products poses a risk of "competing with food" due to the high demand for agricultural resources, which contradicts the goals of sustainable development [2][3]. Group 2: Methanol Production and Capacity - China's methanol production capacity has rapidly expanded, exceeding 100 million tons, with an additional 100 million tons planned, primarily from coal, which accounts for 80% of production [4][5]. - The development of green methanol production using renewable energy sources is gaining traction, with plans for 6 million tons of green methanol capacity by mid-2025, which could support the bio-manufacturing sector and contribute to carbon neutrality goals [5]. Group 3: Weiyuan Synthesis Developments - Weiyuan Synthesis has successfully developed high-efficiency strains for assimilating methanol and is advancing its pipeline for bio-manufactured products, including bulk amino acids and bio-based materials [7]. - This innovation addresses the raw material challenges in bio-manufacturing and helps mitigate the domestic surplus of methanol, while also reducing reliance on imported soybean meal, thereby enhancing food security [7].

Project Overview - The project is named "Micro Yuan Synthesis Green Biological Manufacturing Phase II Health Sugar Project" with an investment of 40 million yuan [2] - The project aims to produce 2,000 tons annually of alitame and mannitol, utilizing existing fermentation and public utility equipment along with new membrane separation, ion exchange, concentration, crystallization, and drying equipment [2] - Alitame is a new low-calorie sweetener with various physiological benefits, while mannitol is widely used in pharmaceuticals, food, and chemicals as a sweetener, humectant, and excipient [2] Ongoing Projects - The "Micro Yuan Synthesis Green Biological Manufacturing Phase II Project" employs biological extraction technology to produce bilirubin from a fermentation process using glucose, citric acid, and other components, with an expected annual production of 5 tons of bilirubin upon completion [3] Company Background - Micro Yuan Synthesis Biotechnology (Qinhuangdao) Co., Ltd. is a wholly-owned subsidiary of Micro Yuan Synthesis Biotechnology (Beijing) Co., Ltd., established in May 2022 and located in the Qinhuangdao High-tech Industrial Development Zone [4] - The company focuses on innovation and industrialization in synthetic biology technology, providing bio-based raw materials and solutions for various industries including pharmaceuticals, daily chemicals, agriculture, food, feed, and materials [4]